KLRK1 and neoplasm: The reduced NKG2D expression on NK cells may be a result of the prolonged engagement by ligands expressed on tumor cells, followed by ligand-induced endocytosis and degradation (Quatrini et al., 2015), or the shedding of NKG2D ligands by tumor cells (Kaiser et al., 2007).